The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders.
Zhang S, Peng X, Yang S, Li X, Huang M, Wei S, Liu J, He G, Zheng H, Yang L, Li H, Fan Q. · 2022
Read The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders. by Zhang S, Peng X, Yang S, Li X, Huang M, Wei S, Liu J, He G, Zheng H, Yang L, Li H, Fan Q. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8825858.txt.
Introduction
Zhang and co-authors review lipophagy, a selective way cells digest their own fat stores. In lipophagy, the cell's cleanup system breaks down lipid droplets. This process helps control stored fat, free fatty acids, and energy balance. It matters across many cell types and body states. Yet how lipids themselves steer this cleanup is still unclear.
The review lays out what lipophagy is and how it is regulated. It then asks what faulty lipophagy does in metabolic disease. Fatty liver disease and metabolic syndrome both appear. Cancer gets a careful, open-ended treatment. The authors note that faulty cleanup can leave cells open to death signals. Readers get a full map of a young research field. Open questions are flagged throughout.
Catalog record
| CREATOR | Zhang S, Peng X, Yang S, Li X, Huang M, Wei S, Liu J, He G, Zheng H, Yang L, Li H, Fan Q. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders By Sheng Zhang, Xueqiang Peng, Shuo Yang, Xinyu Li, Mingyao Huang, Shibo Wei, Jiaxing Liu, Guangpeng He, Hongyu Zheng, Liang Yang, Hangyu Li, Qing Fan Published in: Cell Death & Disease DOI: 10.1038/s41419-022-04593-3 ABSTRACT Autophagy is a conserved method of quality control in which cytoplasmic contents are degraded via lysosomes. Lipophagy, a form of selective autophagy and a novel type of lipid metabolism, has recently received much attention. Lipophagy is defined as the autophagic degradation of intracellular lipid droplets (LDs). Although much remains unknown, lipophagy appears to play a significant role in many organisms, cell types, metabolic states, and diseases. It participates in the regulation of intracellular lipid storage, intracellular free lipid levels (e.g., fatty acids), and energy balance. However, it remains unclear how intracellular lipids regulate autophagy. Impaired lipophagy can cause cells to become sensitive to death stimuli and may be responsible for the onset of a variety of diseases, including nonalcoholic fatty liver disease and metabolic syndrome. Like autophagy, the role of lipophagy in cancer is poorly understood, although analysis of specific autophagy receptors has helped to expand the diversity of chemotherapeutic targets. These studies have stimulated increasing interest in the role of lipophagy in the pathogenesis and treatment of cancer and other human diseases. INTRODUCTION Autophagy has been intensely studied since its discovery. As one of the two evolutionarily conserved cell degradation pathways (autophagic degradation and proteasomal degradation), autophagy maintains a dynamic intracellular balance and can be activated by a variety of different stresses [1–4]. Autophagy is divided into three subtypes (macroautophagy (herein referred to as autophagy), chaperone-mediated autophagy (CMA), and microautophagy), which can be nonselective or selective [5] and include the selective removal of damaged mitochondria by mitophagy and the selective removal of endoplasmic reticulum components by phagocytosis [3, 5–7]. Intracellular lipids are an indispensable source of energy for cells, the structural components of membranes, are synthesized to produce other types of molecules (e.g., hormones), and participate in cell signal transduction. Storing an appropriate amount of lipids to perform cellular functions when needed is essential to cell survival. In 2009, it was discovered that macroautophagy can selectively degrade lipids in hepatocytes; the authors then coined the term “lipophagy” to describe the process [8]. This discovery gave scientists a new perspective and understanding of how lipid metabolism regulates cellular physiology and pathology. Since then, many new functions of autophagic lipid metabolism have been gradually discovered. In this review, we mainly introduce some regulatory effects and functions of lipophagy, including regulating intracellular lipid storage to maintain energy supply under emergency conditions and promoting potential lipotoxic molecular metabolism. Then, we introduce a variety of metabolic disorders in which lipophagy may be involved, including fatty liver disease, and the role of lipophagy in cancer progression. WHAT IS LIPOPHAGY? Lipophagy: a novel type of lipid catabolism Lipid metabolism is a complex metabolic process that includes digestion, absorption, synthesis, catabolism and peroxidation. As one of the most important sources of nutrition, lipids provide energy and essential fatty acids for the human body. Under stress conditions such as hunger and hypoxia, nutrient depletion requires the mobilization of free fatty acids to supply energy, which connects the functions of lipid metabolism, and autophagy. There are three types of lipids: triglycerides (TGs), steroids, and phospholipids [9]. The chemical name of TGs is triacylglycerol (TAG), also known as fat, which is the main lipid storage carrier and consists of one glycerol molecule and three fatty acids. Usually used for ingested food, adipogenesis, the process of TG synthesis, is mainly performed in the liver. TAG is generally stored in lipid droplets (LDs) and is hydrolyzed and metabolized according to the different levels of fat in different parts of the body. Changes in lipid storage are involved a variety of different pathological conditions, including obesity, inflammation, fatty liver, atherosclerosis, neurodegenerative diseases, and cancer. Excessive lipid accumulation can lead to hypoxia, endoplasmic reticulum stress, high immune cell infiltration, increased secretion of proinflammatory cytokines and the development of obesity. Insufficient lipid storage or malnutrition lead to lipotoxicity, mitochondrial dysfunction, increased oxidative stress, and other consequences. Therefore, maintaining proper lipid content is very important for the normal operation of the human body [10]. There are two ways that cells can metabolize stored fats: lipolysis and lipophagy [8, 11]. Once LDs are converted to free fatty acids, they are degraded through mitochondrial fatty acid β-oxidation to meet the energy needs of rapidly proliferating cells [12] (Fig. 1). Lipid metabolism is involved in regulating a variety of cellular processes, including autophagy and the formation of autophagy-related membrane structures. The transfer and degradation of LDs containing TAG through the lysosomal pathway are mediated by autophagy, a process that is now called lipophagy. Lipophagy was originally described in hepatocytes because hepatocytes can accumulate excess lipids. Researchers found that in ATG7 knockout mice, the LD decomposition in mouse hepatocytes depends on autophagy [8].Fig. 1The lipolysis and lipophagy pathways of lipid droplets.a Chaperone-mediated autophagy degrades the LD coat proteins perilipin 2 and perilipin 3 through the coordinated action of heat-shock cognate 71 kDa protein (HSC70) and receptor lysosome-associated membrane glycoprotein 2A (LAMP2A). b Degradation of the LD coat proteins PLP2 and PLP3 allows lipase- and fat-soluble organelles to enter and undergo lipolysis. c Lipophagy induces engulfment of small cytoplasmic lipid droplets or large cytoplasmic lipid droplets by LC3-II-positive membranes. Lipid droplets are transported to lysosomes and degraded by lysosomal acid lipase (LAL). Rab7 promotes the decomposition of LDs by interacting with its downstream effector RILP. The fatty acids produced are mainly directed to the mitochondria to participate in the β-oxidation pathway. It is not surprising that lipid levels affect autophagy levels. Under an electron microscope [13], the number of autophagosomes and the protein level of autophagy factors was decreased in mice with long-term hyperlipidaemia and hereditary obesity. Another study showed that the number of autophagosomes in the liver of obese mice was increased, the fusion of autophagosomes and lysosomes was normal, and autophagy defects were caused by a decrease in cathepsin L and lysosomal acidification defects, which prevented the substrate degradation of autophagic lysosomes [14]. Some studies attempting to assess in vitro autophagosome–lysosome fusion have also reported liver organelle fusion defects in mice fed a high-fat diet [15], which were due to changes in membrane lipid composition caused by the high-fat diet. Defects in the formation and fusion of autophagosomes and the level of substrate degradation may be the mechanism underlying liver autophagy-related injury. Therefore, studying the effect of chronic lipid overload on liver autophagy may be important for the treatment of related diseases. Evidence of lipophagy has been found in models other than HFD-fed mice. It has been shown that 1,3-dichloro-2-propanol can induce lipid accumulation in HepG2 cells by reducing autophagosome formation and impairing lysosomal formation via AKT/mTOR [16]. Several studies have found that a deficiency in selective autophagy is associated with suppression of lipid oxidation. The loss of ATG7 or ATG5 in the liver significantly reduces the production of ketone bodies during hunger or fasting due to the interaction between nuclear receptor coinhibitor 1 (NCoR1) and PPARα; this effect inhibits PPARα transactivation and causes PPARα binding to GABARAP proteins to